Search PubMed⌕ Search

PubMed · 15022474

[Experimental study on brain-computer interface based on visual evoked potentials].

Abstract

Brain-computer interface is a novel EEG-based communication and control system between human brain and computer or some other electric device, which has found important applications in many fields such as rehabilitation engineering. Study has been done in brain-computer interface using visual evoked potentials(VEP). Multiple stimulation patterns were produced on the computer screen through programming. Several flickering blocks were adopted for representing a number of possible selections, and when the subject was fixing his(her) eyes on an object on the screen, the very object could be distinguished by the analysis of the VEPs. Surface electrodes were placed at Oz of the inion and Cz to collect VEP. The wavelet filter and averaging method was used to extract VEP signal. Off-line experimental data analysis indicated that the proposed method may be valuable for developing real brain-computer interface with relatively high accuracy and speed, and the information transfer rates could be higher than 30 bit/min when 12 selections were on the screen.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Qinghua He, Chenglin Peng, Baoming Wu, He Wang. 2004. [Experimental study on brain-computer interface based on visual evoked potentials].. https://pubmed.ncbi.nlm.nih.gov/15022474/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A MAGIBU-based model for pediatric and juvenile CNS tumors: an in-house epigenetic decision-support framework compared with online DNA methylation classifiers.

Background: DNA methylation profiling is a tool that provides key support for central nervous system (CNS) tumor classification. However, diagnostically ambiguous pediatric cases may result in discordant outputs across classifiers. We developed MAGIBU, a cross-platform, projection-based framework that embeds individual methylomes into a fixed CNS reference landscape, ranking diagnostic entities by local epigenetic proximity to support clinician-led integrative diagnosis. Methods: As a proof-of-concept, we evaluated MAGIBU in eight morphologically challenging pediatric/juvenile CNS tumors with unresolved diagnoses after institutional and central pathology review. To establish a benchmark in the absence of a definitive histopathological ground truth, a consensus epigenetic reference was defined a priori for cases showing concordant results between the Heidelberg CNS Tumor Methylation Classifier and Methylscape Analysis. Comparisons were also performed with Epigenomic Digital Pathology (EpiDiP). To validate MAGIBU beyond this discovery cohort, performance was assessed at the family level across the CNS methylation spectrum (n = 678, 28 methylation families), on non-array platforms (whole-genome bisulfite sequencing and Oxford Nanopore), and in a focused analysis of the low-grade glioma and diffuse midline glioma compartment across four independent cohorts (n = 670). Results: In the discovery cohort, MAGIBU achieved high concordance with the consensus reference (Cohen's κ = 0.855), outperforming EpiDiP (κ = 0.278), which frequently placed low-grade tumors in proximity to higher-grade reference regions. Conclusions: MAGIBU provides a stable, quantitative differential diagnosis framework that mitigates the limitations of rigid categorical assignments. By leveraging a distance-based proximity metric, it offers a transparent decision-support tool that integrates effectively with clinical, radiological, and molecular data. While performance is inherently dependent on reference atlas composition, MAGIBU represents a robust complementary approach for the diagnostic workup of ambiguous CNS tumors.

Brain↗

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans.

Low-frequency 1q21.1 distal deletion and duplication copy number variant (CNV) carriers are predisposed to multiple neurodevelopmental disorders, including schizophrenia, autism and intellectual disability. Human carriers display a high prevalence of micro- and macrocephaly in deletion and duplication carriers, respectively. The underlying brain structural diversity remains largely unknown. We systematically called CNVs in 38 cohorts from the large-scale ENIGMA-CNV collaboration and the UK Biobank and identified 28 1q21.1 distal deletion and 22 duplication carriers and 37,088 non-carriers (48% male) derived from 15 distinct magnetic resonance imaging scanner sites. With standardized methods, we compared subcortical and cortical brain measures (all) and cognitive performance (UK Biobank only) between carrier groups also testing for mediation of brain structure on cognition. We identified positive dosage effects of copy number on intracranial volume (ICV) and total cortical surface area, with the largest effects in frontal and cingulate cortices, and negative dosage effects on caudate and hippocampal volumes. The carriers displayed distinct cognitive deficit profiles in cognitive tasks from the UK Biobank with intermediate decreases in duplication carriers and somewhat larger in deletion carriers-the latter potentially mediated by ICV or cortical surface area. These results shed light on pathobiological mechanisms of neurodevelopmental disorders, by demonstrating gene dose effect on specific brain structures and effect on cognitive function.

Brain↗

Audiophile hardware in vision science; the soundcard as a digital to analog converter.

The design objective was to develop an inexpensive digital to analog (D/A) converter for use in vision science. Soundcards are hardware units that can be integral or can be added to a computer to add sound capability. A soundcard contains D/A converters designed to work in the audio frequency range, typically 20-20,000 Hz. Soundcard outputs are high-pass filtered and thus do not convey sub-audio frequency or dc information. It is possible to circumvent this design feature by programming the desired output waveform as an amplitude modulation of a high frequency carrier, and then demodulating the soundcard output. The circuit, using a 20 kHz carrier, provides precise D/A conversion for the frequency range relevant for vision experiments, dc to 100 Hz, using inexpensive readily available components. The specific application was for 8 channels of D/A conversion using a Macintosh computer running under OS X. The software needed to program stimuli was created using CoreAudio, a library for programming sounds in OS X. Using soundcards on other platforms would not be a problem, as long as there exists a low level library that would enable the wave table to be filled.

Brain↗